Encompass Health Corporation (EHC) Stock
NYQ · EHC
123.72
Fundamentals
Market cap
$12.18B
Price / Earnings ratio
19.4x
Price / Sales ratio
1.9x
Price / Book ratio
4.6x
Return on assets
9.0%
Ex-Dividend date
1 Jul 2026
Last payment date
15 Jul 2026
Dividend amount
$0.19
Dividend yield
0.62%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Encompass Health Adds New Capacity With First Small-Format Hospital
NeutralEHCSeptember 25, 2026
Zacks Investment ResearchNeutral
Encompass Health Adds New Capacity With First Small-Format Hospital
EHC

Zacks Investment Research
Encompass Health (EHC) Upgraded to Buy: Here's Why
NeutralEHCSeptember 24, 2026
Zacks Investment ResearchNeutral
Encompass Health (EHC) Upgraded to Buy: Here's Why
EHC

Zacks Investment Research
Here's Why Encompass Health (EHC) is a Strong Growth Stock
NeutralEHCSeptember 18, 2026
Zacks Investment ResearchNeutral
Here's Why Encompass Health (EHC) is a Strong Growth Stock
EHC

Zacks Investment Research
Here's Why Encompass Health (EHC) is a Strong Value Stock
NeutralEHCSeptember 17, 2026
Zacks Investment ResearchNeutral
Here's Why Encompass Health (EHC) is a Strong Value Stock
EHC
Technicals
OscillatorsNeutral5 Indicators
Moving AveragesStrong Buy12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy4
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
7B5B2B0
Debt & Balance Sheet
Total assets
Total liabilities
2025
9B6B3B0
Revenue to Profit
2025$5.9B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$566.2M
Net incomeEarnings
EPS forecast
Actual EPS
$1.40
$1.21
Q2FY25
$1.23
$1.19
Q3FY25
$1.30
Q4FY25
$1.50
Q1FY26
$1.46
Q2FY26
The market is expecting earnings per share of $1.46 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Encompass Health Adds New Capacity With First Small-Format Hospital
NeutralEHCSeptember 25, 2026
Zacks Investment ResearchNeutral
Encompass Health Adds New Capacity With First Small-Format Hospital
EHC

Zacks Investment Research
Encompass Health (EHC) Upgraded to Buy: Here's Why
NeutralEHCSeptember 24, 2026
Zacks Investment ResearchNeutral
Encompass Health (EHC) Upgraded to Buy: Here's Why
EHC

Zacks Investment Research
Here's Why Encompass Health (EHC) is a Strong Growth Stock
NeutralEHCSeptember 18, 2026
Zacks Investment ResearchNeutral
Here's Why Encompass Health (EHC) is a Strong Growth Stock
EHC

Zacks Investment Research
Here's Why Encompass Health (EHC) is a Strong Value Stock
NeutralEHCSeptember 17, 2026
Zacks Investment ResearchNeutral
Here's Why Encompass Health (EHC) is a Strong Value Stock
EHC

Zacks Investment Research
Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?
NeutralEHCSeptember 4, 2026
Zacks Investment ResearchNeutral
Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?
EHC

Zacks Investment Research
How EHC's Capacity Expansion Fuels a Multi-Year Growth Runway
NeutralEHCAugust 25, 2026
Zacks Investment ResearchNeutral
How EHC's Capacity Expansion Fuels a Multi-Year Growth Runway
EHC

Zacks Investment Research
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
NeutralEHCAugust 25, 2026
Zacks Investment ResearchNeutral
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
EHC

Zacks Investment Research
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
NeutralEHCAugust 24, 2026
Zacks Investment ResearchNeutral
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
EHC

Zacks Investment Research
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio
NeutralEHCAugust 21, 2026
Zacks Investment ResearchNeutral
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio
EHC

Zacks Investment Research
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
NeutralEHCAugust 19, 2026
Zacks Investment ResearchNeutral
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
EHC
About Encompass Health Corporation
Encompass Health Corp. engages in the provision of post-acute healthcare services. It provides specialized rehabilitative treatment on an inpatient basis. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
SectorHealthcare
IndustryMedical Care Facilities
Employees29,699
CEOMr. Mark J. Tarr
IPO DateSep 30, 1986
HeadquartersBirmingham, AL
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark J. Tarr | CEO, President & Director | 1962 |
| Mr. Douglas E. Coltharp | Executive VP & CFO | 1962 |
| Mr. Patrick W. Tuer | Executive VP & COO | 1985 |
| Mr. John Patrick Darby | Executive VP, General Counsel & Corporate Secretary | 1965 |
| Dr. Elissa Joy Charbonneau D.O., M.S. | Chief Medical Officer | 1960 |
| Mr. Andrew L. Price | Senior VP & Chief Accounting Officer | 1967 |
| Mr. Rusty Yeager | Chief Information Officer & Senior VP | — |
| Mr. Mark Miller | Senior Vice President of Investor Relations & Strategic Planning | — |
| Ms. Dawn Rock | Chief Compliance Officer | — |
| Mr. Anthony A. Hernandez | Chief Human Resources Officer | 1966 |
Fundamentals
Valuation
Market cap$12.18B
Price-to-sales ratio1.94
Price-to-book value4.63
Price-earnings ratio19.40
Return on Equity25.00%
Return on Sales16.00%
Return on Assets9.00%
PEG ratio0.41
Earnings Per Share
Earnings Per Share$6.22
Income Statement
Average volume853,337
EBITDA$1.28B
1 year high (52w)$127.99
1 year low (52w)$92.77
Dividend
Ex dividend date1 Jul 2026
Dividend amount$0.19
Dividend yield0.62%
Last payment date15 Jul 2026
Dividend yield (TTM)0.61%
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsNeutral5 Indicators
Moving AveragesStrong Buy12 Indicators
What the experts say
4 Wall Street Analyst Ratings
BUY
100% Buy
0% Hold
0% Sell
Target price
$147.25
Est return
19.26%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.0 | -14.0 | -9.8 | +15.3 | ||||||||
| 2022 | -7.2 | +7.4 | +7.1 | -3.9 | -4.0 | -13.3 | +8.8 | -4.2 | -7.1 | +15.8 | +6.0 | +3.5 |
| 2023 | +5.0 | -10.6 | -3.8 | +18.6 | -3.5 | +8.7 | -1.7 | +7.7 | -5.4 | -6.1 | +4.2 | +0.5 |
| 2024 | +5.8 | +1.9 | +11.3 | +0.2 | +4.2 | +2.6 | +8.9 | +0.0 | +3.6 | +3.9 | +4.1 | -9.8 |
| 2025 | +8.1 | -0.4 | +1.5 | +15.5 | +4.3 | +1.5 | -8.6 | +12.2 | +2.7 | -8.6 | +0.1 | -7.5 |
| 2026 | -11.1 | +15.0 | -10.5 | +2.7 | -1.5 | -1.6 | +9.5 | +6.9 | +1.2 |
Corporate actions
Upcoming
DividendQ4/26
Ex-dividend date1 Oct 2026
Payable date15 Oct 2026
Amount per share$0.21
Past
DividendQ3/26
Ex-dividend date1 Jul 2026
Payable date15 Jul 2026
Amount per share$0.19
DividendQ2/26
Ex-dividend date1 Apr 2026
Payable date15 Apr 2026
Amount per share$0.19
DividendQ1/26
Ex-dividend date2 Jan 2026
Payable date15 Jan 2026
Amount per share$0.19
DividendQ4/25
Ex-dividend date1 Oct 2025
Payable date15 Oct 2025
Amount per share$0.19



